Emerging and Novel Therapies for Hepatitis C

Por Jacobson, Ira M.
Publicado em 2010

The HCV Treatment Revolution Continues: Resistance Considerations, Pangenotypic Efficacy, and Advances in Challenging Populations

Por Jacobson, Ira M.
Publicado no Gastroenterol Hepatol (N Y) (2016)

The extinction of chronic viral hepatitis?

Por Kumar, Sonal, Jacobson, Ira M.
Publicado no Clin Liver Dis (Hoboken) (2015)

Advances in the Treatment of Hepatitis C Virus Infection

Por Jesudian, Arun B., Gambarin-Gelwan, Maya, Jacobson, Ira M.
Publicado em 2012

Anemia Management in the Era of Triple Combination Therapy for Chronic HCV

Por Jacobson, Ira M., Kowdley, Kris V., Kwo, Paul Y.
Publicado em 2012

Emerging therapies for the treatment of hepatitis C

Por Lange, Christian M, Jacobson, Ira M, Rice, Charles M, Zeuzem, Stefan
Publicado em 2014

Bacterial Endocarditis Following Deep Enteroscopy: Is Prophylaxis Warranted?

Por Ferm, Samson, Siu, Michael K., Chhetry, Minar, Jacobson, Ira M., Tay, Steven, Rubin, Moshe
Publicado no ACG Case Rep J (2019)

Ribavirin revisited in the era of direct‐acting antiviral therapy for hepatitis C virus infection

Por Feld, Jordan J., Jacobson, Ira M., Sulkowski, Mark S., Poordad, Fred, Tatsch, Fernando, Pawlotsky, Jean‐Michel
Publicado no Liver Int (2016)

Persistence of Hepatitis C Virus during and after Otherwise Clinically Successful Treatment of Chronic Hepatitis C with Standard Pegylated Interferon α-2b and Ribavirin Therapy

Por Chen, Annie Y., Zeremski, Marija, Chauhan, Ranjit, Jacobson, Ira M., Talal, Andrew H., Michalak, Tomasz I.
Publicado em 2013

Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis

Por Dimova, Rositsa B., Zeremski, Marija, Jacobson, Ira M., Hagan, Holly, Des Jarlais, Don C., Talal, Andrew H.
Publicado em 2013

Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection

Por Zeremski, Marija, Dimova, Rositsa B., Pillardy, Jaroslaw, de Jong, Ype P., Jacobson, Ira M., Talal, Andrew H.
Publicado no J Infect Dis (2016)

Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016

Por Li, Andrew A., Kim, Donghee, Kim, Won, Dibba, Pratima, Wong, Katherine, Cholankeril, George, Jacobson, Ira M., Younossi, Zobair M., Ahmed, Aijaz
Publicado no J Viral Hepat (2018)

Depression During Pegylated Interferon-Alpha Plus Ribavirin Therapy: Prevalence and Prediction

Por Raison, Charles L., Borisov, Andrey S., Broadwell, Sherry D., Capuron, Lucile, Woolwine, Bobbi J., Jacobson, Ira M., Nemeroff, Charles B., Miller, Andrew H.
Publicado em 2005

Clonal expansion of immunoglobulin M(+)CD27(+) B cells in HCV-associated mixed cryoglobulinemia

Por Charles, Edgar D., Green, Rashidah M., Marukian, Svetlana, Talal, Andrew H., Lake-Bakaar, Gerond V., Jacobson, Ira M., Rice, Charles M., Dustin, Lynn B.
Publicado em 2008

Intrahepatic Levels of CXCR3-Associated Chemokines Correlate with Liver Inflammation and Fibrosis in Chronic Hepatitis C

Por Zeremski, Marija, Petrovic, Lydia M., Chiriboga, Luis, Brown, Queenie B., Yee, Herman T., Kinkhabwala, Milan, Jacobson, Ira M., Dimova, Rositsa, Markatou, Marianthi, Talal, Andrew H.
Publicado em 2008

Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21(low) B-cell subset

Por Charles, Edgar D., Brunetti, Claudia, Marukian, Svetlana, Ritola, Kimberly D., Talal, Andrew H., Marks, Kristen, Jacobson, Ira M., Rice, Charles M., Dustin, Lynn B.
Publicado em 2011

Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994...

Por Golabi, Pegah, Bush, Haley, Stepanova, Maria, Locklear, Cameron T., Jacobson, Ira M., Mishra, Alita, Trimble, Gregory, Erario, Madeline, Venkatesan, Chapy, Younossi, Issah, Goodman, Zachary, Younossi, Zobair M.
Publicado no Medicine (Baltimore) (2018)

Elbasvir/Grazoprevir in People With Hepatitis C Genotype 1 Infection and Child-Pugh Class B Cirrhosis: The C-SALT Study

Por Jacobson, Ira M., Poordad, Fred, Firpi-Morell, Roberto, Everson, Gregory T., Verna, Elizabeth C., Bhanja, Sanhita, Hwang, Peggy, Caro, Luzelena, Robertson, Michael, Charles, Edgar D., Platt, Heather
Publicado no Clin Transl Gastroenterol (2019)

HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape

Por Reau, Nancy, Fried, Michael W., Nelson, David R., Brown, Robert S., Everson, Gregory T., Gordon, Stuart C., Jacobson, Ira M., Lim, Joseph K., Pockros, Paul J., Reddy, K. Rajender, Sherman, Kenneth E.
Publicado no Liver Int (2015)

Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease

Por Bernstein, David E., Tran, Albert, Martin, Paul, Kowdley, Kris V., Bourliere, Marc, Sulkowski, Mark S., Pockros, Paul J., Renjifo, Boris, Wang, Deli, Shuster, Diana L., Cohen, Daniel E., Jacobson, Ira M.
Publicado no Kidney Int Rep (2018)